Sun Pharma has no plans to get into vaccine production as it requires separate manufacturing infra

The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth

from The Hindu - Business https://ift.tt/3giuPOQ
via IFTTT